Connect your AI

Palvella Therapeutics PVLA Total Assets

Total Assets at other companies

Relay Therapeutics, Inc.RLAY

$699.61M-12.5%

Viridian Therapeutics, Inc.VRDN

$789.02M+19.4%

ANI PharmaceuticalsANIP

$1.42B+10.0%

PrecigenPGEN

$138.63M+7.6%

Arcutis Biotherapeutics, Inc.ARQT

$460M+33.7%

Kodiak Sciences IncKOD

$306.01M+2.7%

Other financials

Income statement

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Cash flow

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Palvella Therapeutics's total assets?: Palvella Therapeutics (PVLA) reported total assets of $263.76M in Q1 2026.
How has Palvella Therapeutics's total assets changed year-over-year?: Palvella Therapeutics's total assets increased by 232.0% year-over-year, from $79.44M to $263.76M.
What is the long-term trend for Palvella Therapeutics's total assets?: Over 5 years (2020 to 2025), Palvella Therapeutics's total assets has grown at a -10.7% compound annual growth rate (CAGR), from $105.01M to $59.56M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.